China Voted Against the World on Fentanyl. Days Later, It Announced a Perfunctory Crackdown.

Op-Ed: Countering China's Chemical Death Pipeline Must Implicate CCP Leadership.

WASHINGTON — One week after the United States publicly shamed Beijing as the only nation in the world to vote against a United Nations resolution targeting the fentanyl precursor supply chain, China’s Hubei Province has announced a series of enforcement actions that typifies the pattern of cosmetic compliance that has allowed the Chinese Communist Party’s structural role in the global fentanyl trade to persist unchallenged.

The Hubei Provincial Narcotics Control Commission announced this week that since December 2025 a special task force had handled 22 cases involving fentanyl precursor chemicals, resulting in the arrest of seven people, criminal coercive measures against 12 others, the administrative detention of one person, and penalties against four companies, state media reported.

Among the actions, according to the CCP’s Xinhua News Agency, Wuhan police — acting on leads provided by the United States Drug Enforcement Administration — apprehended a man identified only as Wang, described as the actual controller of a company found to be selling the controlled psychotropic drug lorazepam and multiple precursor chemicals. A parallel investigation in Hubei and Hebei provinces led to the formal arrest of two suspects, identified as Gao and Wu, accused of registering shell companies to sell controlled psychotropic drugs and uncontrolled chemicals overseas for profit.

The Hubei operation was established under the Ministry of Public Security — placing it within a nationally coordinated enforcement campaign rather than a provincial initiative. The timing traces to a broader diplomatic transaction. In Busan, South Korea at the end of October 2025, China agreed to take steps to curtail the precursor trade in exchange for the Trump administration halving the fentanyl-related tariff on Chinese imports to ten percent.

The Hubei announcement came days after the 69th session of the United Nations Commission on Narcotic Drugs in Vienna, where China cast the lone dissenting vote against a United States-sponsored resolution on supply chain integrity — a resolution designed to prevent the diversion of precursor chemicals and pill-pressing equipment to drug traffickers.

The United States Mission stated that while it was “deeply disappointed that China decided to call a vote, and was the sole country on the commission to vote no,” the commission had nevertheless adopted “a historic U.S.-sponsored resolution on enhancing supply chain integrity.”

The State Department’s Bureau of International Narcotics was more blunt: China, it said, was “the ONLY country to vote NO against a U.S. resolution passed today preventing the sale of precursors and pill presses to drug traffickers,” adding that “inaction speaks for itself.”

Sara Carter, the Director of the White House Office of National Drug Control Policy — a former investigative journalist confirmed as the nation’s drug czar in January 2026 — addressed the commission in Vienna on March 9, four days before the vote. Carter said the precursor chemicals flooding global markets “are manufactured by the millions of tons in China,” and that “China’s weak export controls and lax enforcement allow its chemical industry to foster friendships with the cartels.”

She accused traffickers of “waging a chemical war” — one they could easily sustain “by putting in minimal effort to skirt still-nascent regulations on fentanyl and other deadly precursor chemicals.”

China’s representative at the session, Gao Wei, denied the accusations as unfounded and stated that “one country” was exploiting the drug issue as a pretext for unilateral pressure and interference in the internal affairs of other nations.

The Vienna confrontation was the diplomatic surface of a far deeper problem that United States government investigators have documented in forensic detail. A bipartisan inquiry by the House Select Committee on the Chinese Communist Party found that rather than investigating drug traffickers, Chinese security services have notified targets of American investigations when they received requests for assistance.

The committee further found that the Chinese government, under control of the Chinese Communist Party, provides subsidies to entities that export fentanyl and related precursors — including through tax rebates, monetary grants and awards.

The committee’s investigation surfaced one of the most striking structural findings to emerge from any official inquiry into the fentanyl trade: the presence of Chinese Communist Party officials as shareholders inside fentanyl-exporting chemical companies.

Zhejiang Wangsheng, also known as Zhejiang Netsun, a publicly traded company registered on the Shanghai Stock Exchange, had a Chinese government ownership stake and a Chinese Communist Party member on its board of directors serving as Deputy General Manager — consistent with the government practice of “special management shares.”

That finding was extended in exclusive reporting by The Bureau. A senior United States government expert with oversight of thousands of high-level transnational crime investigations told The Bureau that American investigators have “identified Chinese Communist Party members holding golden shares in the chemical companies shipping precursors out of China.”

The same source described an integrated criminal architecture that spans continents and runs through Canada.

“There are groups that are receiving fentanyl pill press operations — that are doing this in New York City but are also in Canada. And they have roots in both countries. And we know this. This is actual investigative information.”

China, the source told The Bureau, is viewed by American investigators as “upstream” to the Latin cartels and Canadian crime networks that manufacture and distribute synthetic opioids — assembling the product offshore, functioning like a decentralized, China-run factory. China is present at every point in the supply chain, and chooses its partners in North America. “China is on the front end and on the back end of the entire fentanyl system,” the official said.

They added that with aggressive enforcement and relatively forceful laws, American investigators can stamp out synthetic labs on United States soil — which is why Washington is increasingly turning its sights to cartel enterprises inside Mexico, and more recently, Canada.

Perhaps the most visceral illustration of the Chinese Party-state's structural presence came in a ProPublica investigation published in April 2025, which documented that a high-security Chinese government prison in Shijiazhuang, the capital of Hebei province, had owned a chemical company called Yafeng for at least eight years. Yafeng served as the hub of a group of Chinese firms and websites that sold fentanyl products to Americans. The company's English-language websites brazenly offered customers dangerous drugs that are illegal in both nations, promising to smuggle illicit chemicals past border defenses and boasting that its shipments would clear customs with a 100 percent success rate.

Matt Cronin, the former federal prosecutor who led the House inquiry, captured the Party-state’s complicity in a single sentence: “The Chinese government pays you to send drugs to America but executes you for selling them in China. It’s impossible that the Chinese Communist Party doesn’t know what’s going on and can’t do anything about it.”

The State Department’s mandatory congressional report covering the period from March to May 2025 described Beijing’s response to mounting American pressure in terms that apply with equal force to this week’s Hubei announcement. In March 2025, facing pressure from growing attention to the Chinese Communist Party’s role in fueling the synthetic drugs crisis, Beijing released a white paper describing steps it had purportedly taken to control fentanyl-related substances. The paper, the State Department found, obfuscated the nature of the problem, speaking largely to 2019 actions Beijing took to control finished fentanyl and its exports, while the prolific export of chemical precursors continued.

On the question of actual accountability: China had “only reported shutting down some, and not all, companies, and has not shared whether any arrested money launderers were prosecuted and convicted.”